Nine-valent HPV vaccine is one of the most advanced human papillomavirus vaccines at present, which can prevent nine different types of human papillomavirus infection, including two most common carcinogenic human papillomaviruses (human papillomavirus 16 and human papillomavirus 18) and seven carcinogenic human papillomaviruses (human papillomavirus 3 1, 33,45).
The vaccine helps to prevent these human papillomavirus infections by activating the human immune system, thereby reducing the risk of cervical cancer and other related cancers and preventing genital warts. Nine-valent HPV vaccine is suitable for young women and men, and it is best to vaccinate them before they start sexual activities, because it can provide better protection.
Nine-valent human papillomavirus vaccination usually requires multiple injections, and the specific vaccination scheme may vary from region to region and medical institutions. Generally speaking, the interval between vaccinations is 0, 2 and 6 months, with three doses of vaccine. Following the vaccination plan is the key to ensure the best protection.
Nine-valent HPV vaccine can significantly reduce the risk of infection-related human papillomavirus type and reduce the occurrence of human papillomavirus-related diseases. However, it cannot completely prevent all cancers related to human papillomavirus, so it is still very important for women to have regular cervical cancer screening.
If you are interested in the nine-valent HPV vaccine, it is recommended to consult a medical professional to learn more about the suitable population, vaccination time and vaccination plan. Only by vaccinating on the advice of a doctor can the maximum protective effect be obtained. Patients in need can consult or purchase through formal overseas medical platforms (such as Hong Kong Maijikang Medical Center).